The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Properties left behind in market rally

Tue, 18th Aug 2009 12:00

Once again mining stocks are in the driving seat but today they are driving the market north, with many stocks recovering some of yesterday's heavy losses.Xstrata, ENRC, Kazakhmys and Lonmin are the picks of the mining sector, along with cash strapped Rio Tinto, which has received a $2.025bn offer for the majority of its Alcan Packaging business. Rio said the binding offer has been received from Amcor and covers the Alcan Packaging global pharmaceuticals, global tobacco, food Europe and food Asia divisions. British Land's results have disappointed and cast a shadow over the real estate sector. The property group, which owns the Broadgate development in London's financial district, saw the value of its property portfolio fall to £8.18bn in the first quarter but said the pace of decline has slowed markedly. Land Securities and Liberty International slide in sympathy.Elsewhere in the financial sector HSBC is wanted after positive comment from Goldman Sachs. The US bank reckons that HSBC Finance will stop being a major drag on HSBC's earnings from 2010 onwards, earlier than previously expected. Goldman Sachs has upgraded HSBC from 'neutral' to 'buy' and raised its price target from 580p to 820p.A joint venture including support services firm Carillion has won a 'Building Schools for the Future' contract for Durham. The market has given the thumbs up to James Fisher's acquisition of MB Faber, which provides specialist electrical and engineering services to the nuclear and aerospace industries, for up to £5.25m in cash.Car dealer Pendragon reported sharply lower profits in the six months to June 30 as recession-hit motorists held onto their old cars rather than splashing out on new ones. Respiratory inhaler firm Vectura remains "very confident" about prospects with important drug trials due to start later this year and plenty of cash in the bank.Online video services provider Amino Technologies posted an operating loss compared with a profit the same time a year before as challenging economic conditions continued hit the group. Nightclub owner Luminar can breathe a little easier on news that 95.5% of the shares available through an open offer have been taken up and buyers have been found for the remainder.Chip designer Arc International is recommending a £25.2m cash bid from US semiconductor intellectual property firm Virage Logic.The slump in construction activity hit property repair and maintenance company Rok hard in the first half of 2009, but the company is confident of meeting full year expectations, provided market conditions do not deteriorate further.Australian alternative energy developer Ceramic Fuel Cells revealed widening annual losses after it booked significant impairment charges related to losses on financial investments.US navigation equipment specialist Garmin said any offer it makes for marine electronics group Raymarine is likely to be solely in cash. Yesterday, Raymarine confirmed recent press speculation that it is in potential takeover talks with US navigation equipment specialist Garmin and with other parties.Zambia-based exploration company Kiwara said its follow-up drill programme has significantly extended the size of the strike at the company's mne in Kawako.India-focused oil and gas company Indus Gas has discovered gas on a test drilling of a new well. The Eastern Promise-1 well intersected a gas bearing interval at a depth of around 3,175 to 3,183 metres in the Early Cretaceous Pariwar formation.Trading in the shares of Dominion Petroleum resumed after the Bermuda-based oil and gas explorer announced a cash injection and its results for 2008. The company is to raise $10m through the issue of new shares to BlueGold Capital. The share purchase will give BlueGold a 20% stake in Dominion. The company said it made a pre-tax loss of $20.67m in 2008, an improvement on the $24.50m loss made in 2007.FTSE 100 - RisersXstrata (XTA) 775.50p +4.51%Eurasian Natural Resources (ENRC) 784.50p +3.43%Kazakhmys (KAZ) 892.00p +3.30%Rio Tinto (RIO) 2,318.50p +3.25%FTSE 100 - FallersInvensys (ISYS) 245.60p -2.77%Land Securities Group (LAND) 597.00p -2.13%British Land Co (BLND) 486.80p -1.89%Petrofac Ltd (PFC) 865.50p -1.87%
More News
18 Dec 2020 08:12

Hikma rallies as it launches generic version of Glaxo asthma treatment

(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.

Read more
17 Dec 2020 18:10

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Read more
4 Dec 2020 13:05

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

Read more
30 Nov 2020 09:53

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Read more
30 Nov 2020 08:06

Vectura signs asthma treatment deal with Kinaset

(Sharecast News) - Vectura has signed a global licence and development deal with Kinaset Therapeutics of the US for the development and commercialisation of the VR588 pan-JAK asthma treatment.

Read more
20 Nov 2020 08:34

Court denies GSK appeal in Vectura intellectual property dispute

(Sharecast News) - Inhalation-focussed contract design and manufacture organisation Vectura Group announced on Friday that the United States Court of Appeals for the Federal Circuit has denied GlaxoSmithKline's (GSK) motions for judgment as a matter of law, a new trial on infringement, and for a new trial on damages in litigation concerning Vectura's US patent 8303991.

Read more
19 Nov 2020 20:25

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

Read more
28 Sep 2020 15:53

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

Read more
22 Sep 2020 19:34

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

Read more
15 Sep 2020 17:22

Vectura Revenue Slips But Swings To First Half Profit

Vectura Revenue Slips But Swings To First Half Profit

Read more
14 Sep 2020 17:21

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

Read more
2 Sep 2020 19:36

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

Read more
7 Jul 2020 16:35

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

Read more
9 Jun 2020 12:04

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

Read more
8 Jun 2020 15:00

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.